TCL Archive NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available October 5, 1984
TCL Archive Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala June 18, 1993
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
